blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1624888

EP1624888 - MULTIVALENT MENINGOCOCCAL DERIVATIZED POLYSACCHARIDE-PROTEIN CONJUGATES AND CORRESPONDING VACCINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.08.2017
Database last updated on 11.09.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Sanofi Pasteur, Inc.
Route 611 Discovery Drive
Swiftwater, PA 18370 / US
[2016/41]
Former [2006/07]For all designated states
Sanofi Pasteur, Inc.
Route 611 Discovery Drive
Swiftwater, PA 18370 / US
Inventor(s)01 / RYALL, Robert, P.
411 Main Street
Stroudsburg, PA 18360 / US
 [2006/07]
Representative(s)Wilding, James Roger, et al
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2016/41]Wilding, James Roger, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
Former [2006/26]Lawrence, Malcolm Graham, et al
HLBBshaw Merlin House Falconry Court Baker's Lane
Epping, Essex CM16 5DQ / GB
Former [2006/07]Furlong, Isla Jane, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date04751728.907.05.2004
[2006/07]
WO2004US14466
Priority number, dateUS20030468581P07.05.2003         Original published format: US 468581 P
[2006/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004103400
Date:02.12.2004
Language:EN
[2004/49]
Type: A2 Application without search report 
No.:EP1624888
Date:15.02.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 02.12.2004 takes the place of the publication of the European patent application.
[2006/07]
Type: B1 Patent specification 
No.:EP1624888
Date:12.10.2016
Language:EN
[2016/41]
Search report(s)International search report - published on:EP24.03.2005
ClassificationIPC:A61K39/095
[2006/07]
CPC:
A61K39/095 (EP,US); A61P31/04 (EP); A61P37/02 (EP);
A61P37/04 (EP); A61P43/00 (EP); A61K2039/55505 (EP,US);
A61K2039/6037 (EP,US); A61K2039/6081 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/41]
Former [2006/07]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesLT20.01.2006
LV20.01.2006
TitleGerman:MULTIVALENTE DERIVATISIERTE MENINGOCOCCALE POLYSACCHARID-PROTEINKONJUGATE UND ENTSPRECHENDE VAKZINE[2006/07]
English:MULTIVALENT MENINGOCOCCAL DERIVATIZED POLYSACCHARIDE-PROTEIN CONJUGATES AND CORRESPONDING VACCINE[2006/07]
French:CONJUGUES DE POLYSACCHARIDES-PROTEINES DERIVATISES MENINGOCOCCIQUES MULTIVALENTS ET VACCIN CORRESPONDANT[2006/07]
Entry into regional phase06.12.2005National basic fee paid 
06.12.2005Designation fee(s) paid 
06.12.2005Examination fee paid 
Examination procedure09.12.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
06.12.2005Amendment by applicant (claims and/or description)
06.12.2005Examination requested  [2006/07]
06.03.2008Despatch of a communication from the examining division (Time limit: M04)
15.05.2008Reply to a communication from the examining division
16.07.2009Despatch of a communication from the examining division (Time limit: M06)
10.05.2010Reply to a communication from the examining division
20.02.2012Despatch of a communication from the examining division (Time limit: M06)
10.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
20.12.2012Reply to a communication from the examining division
25.06.2015Despatch of a communication from the examining division (Time limit: M06)
10.12.2015Reply to a communication from the examining division
10.08.2016Communication of intention to grant the patent
02.09.2016Fee for grant paid
02.09.2016Fee for publishing/printing paid
02.09.2016Receipt of the translation of the claim(s)
Divisional application(s)EP10183290.5  / EP2386313
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.03.2008
Opposition(s)13.07.2017No opposition filed within time limit [2017/38]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.12.2012Request for further processing filed
20.12.2012Full payment received (date of receipt of payment)
Request granted
17.01.2013Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
10.05.2010Request for further processing filed
10.05.2010Full payment received (date of receipt of payment)
Request granted
27.05.2010Decision despatched
Fees paidRenewal fee
14.06.2006Renewal fee patent year 03
14.05.2007Renewal fee patent year 04
14.05.2008Renewal fee patent year 05
12.05.2009Renewal fee patent year 06
31.03.2010Renewal fee patent year 07
11.05.2011Renewal fee patent year 08
30.03.2012Renewal fee patent year 09
10.05.2013Renewal fee patent year 10
31.03.2014Renewal fee patent year 11
12.05.2015Renewal fee patent year 12
10.05.2016Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
31.05.200603   M06   Fee paid on   14.06.2006
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.05.2004
AT12.10.2016
CY12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
TR12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
IE07.05.2017
LU07.05.2017
[2020/15]
Former [2019/46]HU07.05.2004
AT12.10.2016
CY12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
IE07.05.2017
LU07.05.2017
Former [2019/31]HU07.05.2004
AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
IE07.05.2017
LU07.05.2017
Former [2018/23]AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
IE07.05.2017
LU07.05.2017
Former [2018/17]AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
LU07.05.2017
Former [2018/06]AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
LU31.05.2017
Former [2017/52]AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
LU31.05.2017
Former [2017/38]AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
PT13.02.2017
LU31.05.2017
Former [2017/36]AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SK12.10.2016
GR13.01.2017
PT13.02.2017
LU31.05.2017
Former [2017/35]AT12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
GR13.01.2017
PT13.02.2017
Former [2017/33]AT12.10.2016
DK12.10.2016
ES12.10.2016
FI12.10.2016
NL12.10.2016
PL12.10.2016
SE12.10.2016
GR13.01.2017
PT13.02.2017
Former [2017/29]AT12.10.2016
ES12.10.2016
FI12.10.2016
NL12.10.2016
PL12.10.2016
SE12.10.2016
GR13.01.2017
PT13.02.2017
Cited inInternational search[X]US5965714  (RYALL ROBERT P [US]) [X] 1-65 * column 1, line 29 - line 33 * * column 2, paragraph LAST * * column 5, paragraph 3 - column 13, line 60 * * examples 7-9; table 1 *;
 [X]US2003035806  (D AMBRA ANELLO J [US], et al) [X] 1-14 * examples 1-5 *;
 [X]  - "DOSE ESCALATION, SAFETY AND IMMUNOGENICITY STUDY OF A TETRAVALENT MENINGOCOCCAL POLYSACCHARIDE DIPHTHERIA CONJUGATE VACCINE IN TODDLERS", PEDIATRIC INFECTIOUS DISEASE JOURNAL, WILLIAMS & WILKINS, BALTIMORE, MD, US, (200210), vol. 21, no. 10, ISSN 0891-3668, pages 978 - 979, XP008015582 [X] 1-65 * the whole document *

DOI:   http://dx.doi.org/10.1097/00006454-200210000-00019
 [X]  - CAMPAGNE G ET AL, "SAFETY AND IMMUNOGENICITY OF THREE DOSES OF A NEISSERIA MENINGITIDIS A + C DIPHTHERIA CONJUGATE VACCINE IN INFANTS FROM NIGER", PEDIATRIC INFECTIOUS DISEASE JOURNAL, WILLIAMS & WILKINS, BALTIMORE, MD, US, (200002), vol. 19, no. 2, ISSN 0891-3668, pages 144 - 150, XP008015581 [X] 1-65 * abstract * * page 144, column R, paragraph 1 * * page 145, column L, paragraph 3; tables 3,4 *

DOI:   http://dx.doi.org/10.1097/00006454-200002000-00013
 [X]  - PELTOLA H, "MENINGOCOCCAL VACCINES CURRENT STATUS AND FUTURE POSSIBILITIES", DRUGS, ADIS INTERNATIONAL LTD, AT, (199803), vol. 55, no. 3, ISSN 0012-6667, pages 347 - 366, XP008022620 [X] 1-65 * page 350, column R, paragraph 3 - page 351, column L, paragraph 1 * * page 359, column L, paragraph 3 - page 360, column L *

DOI:   http://dx.doi.org/10.2165/00003495-199855030-00003
 [PX]  - HARRIS SHANNON L ET AL, "Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine.", INFECTION AND IMMUNITY, (200306), vol. 71, no. 6, ISSN 0019-9567, pages 3402 - 3408, XP002309706 [PX] 1,21,45,48-50 * abstract * * page 3403, column L, paragraph 2 *

DOI:   http://dx.doi.org/10.1128/IAI.71.6.3402-3408.2003
 [T]  - CHIPPAUX J-P ET AL, "Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20040903), vol. 22, no. 25-26, ISSN 0264-410X, pages 3303 - 3311, XP004526904 [T] 1-65 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2004.02.028
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.